Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Journal of Hematology & Oncology|May 19, 2015
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation statusWenzhao Zhong, Xuening Yang, Honghong Yan, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 27, 2025
[ADAR1 Regulates the ERK/c-FOS/MMP-9 Pathway to Drive the Proliferation and Migration of Non-small Cell Lung Cancer Cells]Li Zhang, Xue Pan, Wenqing Yan, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 21, 2023
[SWI/SNF Complex Gene Mutations Promote the Liver Metastasis of Non-small Cell Lung Cancer Cells in NSI Mice]Lingling Gao, Zhi Xie, Shouheng Lin, et al.Oncoimmunology|December 15, 2018
DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cellsRuocong Zhao, Lin Cheng, Zhiwu Jiang, et al.Journal of Hematology & Oncology|March 15, 2017
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cellsLe Qin, Yunxin Lai, Ruocong Zhao, et al.Oncogene|December 4, 2020
Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinomaXuewen Liu, Fang Wang, Chunwei Xu, et al.Biomarker Research|June 10, 2020
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growthLe Qin, Ruocong Zhao, Dongmei Chen, et al.Oncoimmunology|April 14, 2017
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cellsXinru Wei, Yunxin Lai, Jin Li, et al.Thoracic Cancer|September 7, 2020
Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+ CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancerHongling Liang, Hongsheng Li, Zhi Xie, et al.Frontiers in Oncology|December 24, 2021
TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast CancerHongling Liang, Jia Huang, Xiang Ao, et al.Pageof 6